Most of it is settled. One choice is yours.
02What the data settled
- Creatine + protein is the buyable substance — but demand is anxious / reassurance-led, not confident. The deck's creatine removal was based on a false premise → reverse it.
- Stress is the emotional wrapper, not a product — mostly venting, partly clinical, partly creator-noise. Speak to it; don't build a SKU on it.
- Brain fog / "claridad mental" is the through-line benefit — bridges substance and emotion.
- One SKU, not a range — the concerns don't cluster (12 of 3,732 carry all four).
- Perimenopause is discounted — 30.4% anchor artifact, 40+, creator-led.
03The open decision — cohort × format
Creatine demand skews 40+. Coffee is something the 40+ cohort is quitting. Rafa reaches sub-40. Substance, format and channel don't align — choosing the cohort resolves all three.
Sub-40 beachhead
Format
Coffee (fits — not quitting)
Framing
Energy + clarity; creatine as clean, safe, no-bloat
For
Format + Rafa + reassurance all align
Against
Smaller TAM; creatine thinnest here (n=16); low-spend core
Follow demand (40+)
Format
Matcha / stick / capsule (not coffee)
Framing
Muscle + clarity + transition
For
Largest, most buyable demand sits here
Against
Drops coffee + Rafa; peri lane is artifact-inflated; creator-saturated
Format-flex
Format
Coffee + matcha/decaf variant
Framing
Clarity + calm, format-agnostic
For
Spans both; captures coffee-quitters
Against
Two SKUs at launch — breaks single-SKU focus; more COGS/lab
The questions that decide it: Is Rafa's reach a repeatable engine or a one-time list? · What CAC can we afford? · Coherence or size? · Is creatine-in-coffee an ownable wedge? · How much does brand essence matter day one?
04Concern landscape · ES · click to sort · composite = size×emotion×buy-moment
| Concern | Mentions | Buyable | Composite |
|---|---|---|---|
| creatine_curiosity | 275 | 0.95 | 1.27 |
| stress_cortisol | 402 | 0.47 | 1.09 |
| energy_fatigue | 308 | 0.59 | 0.98 |
| perimenopause* | 303 | 0.43 | 0.75 |
| muscle_maintenance | 169 | 0.83 | 0.69 |
| sleep | 201 | 0.60 | 0.68 |
| calm_energy | 106 | 0.59 | 0.32 |
Creatine is #1 on the chosen metric despite the lowest emotion — it wins on buy-intent. *Peri inflated (§02). Velocity slopes are untrusted (sources turned on mid-2025); Dan's external search is the only clean growth read.
05Buyable vs. ventable
| creatine | 0.95 | SUBSTANCE | |
| energy_fatigue | 0.59 | mixed | |
| stress_cortisol | 0.47 | WRAPPER | |
| perimenopause | 0.43 | venting |
Creatine is what they shop for; stress is what they feel. But the buyable number flatters creatine — the language under it is fear, not confidence (§06).
06What the language said
Creatine demand is anxious — the "seeking" is safety-seeking, not brand comparison:
→ The hero job is removing fear: clean, women-formulated, no-bloat, safe, drinkable in coffee. Stress is everyday overwhelm ("no llego a todo," "no puedo con mi alma") — but partly clinical, so the wrapper speaks to overwhelm, never anxiety. Clarity is the prize word: "claridad mental." And 40+ women are leaving coffee: "café no tomo," matcha "sin tembladera ni bajón" — which is the heart of the §03 decision.
07Risks & open gates
Cohort × format (§03) — unresolved by design; changes formula + positioning at the root.
Creatine velocity. Slopes untrusted; Dan's ES search cross-check is the only clean growth read.
Category is creator/seller-saturated beyond our anchors — read signal accordingly.
Creatine fear is the conversion barrier — bloating, hair-loss, drug-interaction. Win on reassurance.
Geo gate cleared honestly at 36.3% ES. Clinical-stress content must never be targeted.